Search Results 7601-7610 of 40896 for oral

  1. Publications - Michael F. Neblett, II, M.D. - Mayo Clinic

    Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas. Obstet Gynecol. 2023 May 01; 141(5):901-910. Epub 2023 Apr 05. View ...

  2. A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2 - Mayo Clinic

    May be on oral therapy (including metformin) or insulin. Most recent HgbA1c level measuring between 6.5 -10 within the last 3 months. May be on stable (> 4 ...

  3. Steroid dosage risks and benefits when managing lupus nephritis - Mayo Clinic News Network

    ... oral steroids. "Steroids have been used for 75 years, but there was minimal evidence about dosing," says Dr. Duarte García. "This research provides ...

  4. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

    * Participant has demonstrated intolerance or inadequate response to one or more of the following categories of drugs: aminosalicylates, oral locally acting ...

  5. centers-of-excellence

    Location Rochester, Minnesota Clinical Profile SUMMARY Dr. Torgerson's areas of clinical and research interest include: Oral and genital mucosal disorders ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery ... Oral and thr...oat cancer, Head and neck cancer, Mouth cancer, Thyroid ...

  7. A multidisciplinary approach to head and neck cancer

    We're probably one of the most aggressive centers in looking at dose de-escalation in terms of radiation for patients with HPV-related oral pharynx cancers.

  8. Safety Study Of CC-93538 In Adult And Adolescent Participants With Eosinophilic Esophagitis - Mayo Clinic

    Use of these agents is prohibited during the study. - Treatment with oral or sublingual immunotherapy within 6 months of OLE Day 1. Use of these agents is ...

  9. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

    Administration of oral immunosuppressants when the dose has NOT been stable during the preceding 2 months (2 weeks for long-term corticosteroid therapy) and ...

  10. Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) - Mayo Clinic

    Acceptable methods include surgical sterilization, hormonal contraceptives (such as oral contraceptives, Depo-Provera, NuvaRing), condoms used with a spermicide ...